MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$296,683K Accounts receivable$123,330K Short-term investments$86,644K Inventory$24,887K Prepaid expenses andother current assets$18,140K Total current assets$549,684K Intangible assets, net$260,921K Other assets$12,018K Operating leaseright-of-use assets$8,741K Long-term investments$8,105K Property and equipment,net$1,862K Restricted cash$1,482K Total assets$842,813K Total liabilities andstockholders equity$842,813K Total liabilities$528,123K Total stockholdersequity$314,690K Accumulated deficit-$667,544K Convertible notes payable,net, noncurrent$309,797K Total currentliabilities$205,799K Operating leaseliabilities, noncurrent$7,516K Other liabilities$5,011K Additional paid-in capital$981,878K Accumulated othercomprehensive income (loss)$351K Common stock, 0.0001par value...$5K Accrued expenses andother current...$196,185K Accounts payable$9,614K
Balance Sheet
source: myfinsight.com

Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals, Inc. (MIRM)